Details of the Drug Formulaction

General Information of Drug Formulation (ID: F20849)

• Formulation Name: Temozolomide 180 mg capsule
• Company: Mylan Pharamceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Temozolomide	(DMKECZD)	Adenocarcinoma	2D40	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Ammonia	(E00007)	222	Alkalizing agent
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Eisenoxyd	(E00585)	56841934	Colorant
Ferric hydroxide oxide yellow	(E00539)	23320441	Colorant
Ferrosoferric oxide	(E00231)	14789	Colorant
Propylene glycol	(E00040)	1030	Antimicrobial preservative; Humectant; Plasticizing agent; Solvent
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Stearic acid	(E00079)	5281	Emulsifying agent; Solubilizing agent; Viscosity-controlling agent; lubricant
Tartaric acid	(E00029)	875	Acidulant; Complexing agent; Flavoring agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent